180 related articles for article (PubMed ID: 31850964)
21. Radioprotective role of amifostine on osteointegration of titanium implants in the tibia of rats.
Aydemir Celep N; Kara H; Erbaş E; Doğan E
J Vet Sci; 2023 May; 24(3):e35. PubMed ID: 37271503
[TBL] [Abstract][Full Text] [Related]
22. Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): preclinical aspects.
Peters GJ; van der Vijgh WJ
Eur J Cancer; 1995; 31A Suppl 1():S1-7. PubMed ID: 7577093
[TBL] [Abstract][Full Text] [Related]
23. Sequential histomorphometric analysis of the growth plate following irradiation with and without radioprotection.
Damron TA; Margulies BS; Strauss JA; O'Hara K; Spadaro JA; Farnum CE
J Bone Joint Surg Am; 2003 Jul; 85(7):1302-13. PubMed ID: 12851356
[TBL] [Abstract][Full Text] [Related]
24. The differential effects of the radioprotectant drugs amifostine and sodium selenite treatment in combination with radiation therapy on constituent bone cells, Ewing's sarcoma of bone tumor cells, and rhabdomyosarcoma tumor cells in vitro.
Margulies BS; Damron TA; Allen MJ
J Orthop Res; 2008 Nov; 26(11):1512-9. PubMed ID: 18473385
[TBL] [Abstract][Full Text] [Related]
25. [Amifostine: current and future applications in cytoprotection].
Lenoble M
Bull Cancer; 1996 Sep; 83(9):773-87. PubMed ID: 8952658
[TBL] [Abstract][Full Text] [Related]
26. Advances of Amifostine in Radiation Protection: Administration and Delivery.
Ji L; Cui P; Zhou S; Qiu L; Huang H; Wang C; Wang J
Mol Pharm; 2023 Nov; 20(11):5383-5395. PubMed ID: 37747899
[TBL] [Abstract][Full Text] [Related]
27. Radioprotectants: pharmacology and clinical applications of amifostine.
Dorr RT
Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):10-3. PubMed ID: 9794995
[TBL] [Abstract][Full Text] [Related]
28. The protective effect of amifostine on radiation-induced acute pulmonary toxicity: detection by (99m)Tc-DTPA transalveolar clearances.
Uzal C; Durmus-Altun G; Caloglu M; Ergülen A; Altaner S; Yigitbasi NO
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):564-9. PubMed ID: 15380593
[TBL] [Abstract][Full Text] [Related]
29. Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer.
Antonadou D; Petridis A; Synodinou M; Throuvalas N; Bolanos N; Veslemes M; Sagriotis A
Semin Oncol; 2003 Dec; 30(6 Suppl 18):2-9. PubMed ID: 14727235
[TBL] [Abstract][Full Text] [Related]
30. Selective radioprotection of hepatocytes by systemic and portal vein infusions of amifostine in a rat liver tumor model.
Symon Z; Levi M; Ensminger WD; Smith DE; Lawrence TS
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):473-8. PubMed ID: 11380236
[TBL] [Abstract][Full Text] [Related]
31. WR-1065, the active metabolite of amifostine, mitigates radiation-induced delayed genomic instability.
Dziegielewski J; Baulch JE; Goetz W; Coleman MC; Spitz DR; Murley JS; Grdina DJ; Morgan WF
Free Radic Biol Med; 2008 Dec; 45(12):1674-81. PubMed ID: 18845240
[TBL] [Abstract][Full Text] [Related]
32. Amifostine as a radioprotectant.
Gosselin TK; Mautner B
Clin J Oncol Nurs; 2002; 6(3):175-6, 180. PubMed ID: 11998614
[No Abstract] [Full Text] [Related]
33. Sparing of radiation-induced damage to the physis: fractionation alone compared to amifostine pretreatment.
Damron TA; Spadaro JA; Tamurian RM; Damron LA
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1067-71. PubMed ID: 10863080
[TBL] [Abstract][Full Text] [Related]
34. Hypofractionated and accelerated radiotherapy with amifostine cytoprotection (HypoARC): a new concept in radiotherapy and encouraging results in breast cancer.
Koukourakis MI
Semin Oncol; 2002 Dec; 29(6 Suppl 19):42-6. PubMed ID: 12577243
[TBL] [Abstract][Full Text] [Related]
35. Amifostine and radiation therapy: past, present, and future.
Tannehill SP; Mehta MP
Semin Oncol; 1996 Aug; 23(4 Suppl 8):69-77. PubMed ID: 8783671
[TBL] [Abstract][Full Text] [Related]
36. Transiently increased bone density after irradiation and the radioprotectant drug amifostine in a rat model.
Margulies B; Morgan H; Allen M; Strauss J; Spadaro J; Damron T
Am J Clin Oncol; 2003 Aug; 26(4):e106-14. PubMed ID: 12902907
[TBL] [Abstract][Full Text] [Related]
37. Quantitative histologic evidence of amifostine-induced cytoprotection in an irradiated murine model of mandibular distraction osteogenesis.
Tchanque-Fossuo CN; Donneys A; Razdolsky ER; Monson LA; Farberg AS; Deshpande SS; Sarhaddi D; Poushanchi B; Goldstein SA; Buchman SR
Plast Reconstr Surg; 2012 Dec; 130(6):1199-1207. PubMed ID: 22878481
[TBL] [Abstract][Full Text] [Related]
38. A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy.
Feng M; Smith DE; Normolle DP; Knol JA; Pan CC; Ben-Josef E; Lu Z; Feng MR; Chen J; Ensminger W; Lawrence TS
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1441-7. PubMed ID: 22440042
[TBL] [Abstract][Full Text] [Related]
39. Does amifostine have a role in chemoradiation treatment?
Brizel DM; Overgaard J
Lancet Oncol; 2003 Jun; 4(6):378-81. PubMed ID: 12788413
[TBL] [Abstract][Full Text] [Related]
40. Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC).
Khodarev NN; Kataoka Y; Murley JS; Weichselbaum RR; Grdina DJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):553-63. PubMed ID: 15380592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
